Medtronic (NYSE: MDT): Vanguard reports 10.21% beneficial stake in Schedule 13G/A
Rhea-AI Filing Summary
The Vanguard Group has updated its ownership disclosure for Medtronic PLC. The firm reports beneficial ownership of 130,949,305 shares of Medtronic common stock, representing 10.21% of the class. Vanguard reports no sole voting power over these shares, with shared voting power over 7,668,852 shares. It has sole dispositive power over 118,346,690 shares and shared dispositive power over 12,602,615 shares.
The filing states that the securities were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of Medtronic. Vanguard indicates that its clients, including registered investment companies and other managed accounts, have the right to receive dividends or sale proceeds from these securities, and no single other person has an interest in more than 5% of the class.
Positive
- None.
Negative
- None.